O'Brien J S, Storb R, Raff R F, Harding J, Appelbaum F, Morimoto S, Kishimoto Y, Graham T, Ahern-Rindell A, O'Brien S L
Department of Neurosciences, School of Medicine, University of California, San Diego, La Jolla.
Clin Genet. 1990 Oct;38(4):274-80. doi: 10.1111/j.1399-0004.1990.tb03581.x.
Allogeneic bone marrow transplantation was carried out in an 81-day-old Portuguese water dog with GM1 gangliosidosis using a DLA identical sibling as donor. Engraftment was complete and beta-galactosidase activity in leukocytes of the transplanted dog were similar to those in the donor. Over the next 2.5 months neurological deterioration in the transplanted dog was similar to that in untreated dogs with GM1 gangliosidosis. Cerebral ganglioside GM1 concentrations were not diminished by bone marrow transplantation and cerebral beta-galactosidase activity was negligible. We conclude that allogeneic bone marrow transplantation early in life is ineffective in canine GM1 gangliosidosis.
对一只患有GM1神经节苷脂贮积症的81日龄葡萄牙水犬进行了同种异体骨髓移植,供体为一只DLA相同的同胞犬。移植成功,移植犬白细胞中的β-半乳糖苷酶活性与供体相似。在接下来的2.5个月里,移植犬的神经功能恶化情况与未治疗的GM1神经节苷脂贮积症犬相似。骨髓移植并未降低大脑神经节苷脂GM1的浓度,大脑中的β-半乳糖苷酶活性可忽略不计。我们得出结论,幼年时进行同种异体骨髓移植对犬GM1神经节苷脂贮积症无效。